Swedish Online Retail and Ecommerce Stock News

Yubico (OM:YUBICO) FY 2025 earnings snapshot Yubico (OM:YUBICO) has wrapped up FY 2025 with Q4 revenue of 548.3 million SEK and basic EPS of 0.04 SEK, setting the tone for a year where trailing 12 month revenue came in at 2.2 billion SEK and basic EPS was 1.49 SEK. The company has seen quarterly revenue move between 499.1 million SEK and 623.1 million SEK over the past year, with basic EPS ranging from 0.04 SEK to 0.74 SEK. Trailing 12 month EPS and net income have tracked alongside 12 month...

Verisure (OM:VSURE) FY 2025 Earnings Snapshot Verisure (OM:VSURE) has wrapped up FY 2025 with fourth quarter revenue of €964.7 million and a basic EPS loss of €0.12, while trailing 12 month figures show revenue of about €3.7 billion and a basic EPS loss of €0.30. Over the past year, the company has seen revenue move from €870.2 million in Q4 2024 to €964.7 million in Q4 2025, while quarterly EPS stayed in loss making territory, shifting from a €0.07 loss per share in Q4 2024 to a €0.12 loss...

If you are looking at EQT and wondering whether the current share price still offers value, this article will walk you through what the numbers actually say about the stock. The share price last closed at SEK 290.30, with returns of 2.0% over 7 days, a 19.4% decline over 30 days, and returns of 20.7% over 3 years and 21.8% over 5 years that give useful longer term context. Recent coverage of EQT has focused on how the stock's shorter term pullback sits against its longer term record. This...

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...

What recent performance says about Embracer Group (OM:EMBRAC B) Embracer Group (OM:EMBRAC B) has seen its share price move sharply in different directions, with a 19% gain over the past week and a 38% decline over the past 3 months. This places recent momentum in contrast with a weaker medium term trend. See our latest analysis for Embracer Group. At a share price of SEK54.47, Embracer Group’s sharp 18.7% 7 day share price return comes after a weaker stretch, with the 1 year total shareholder...

As global markets navigate a period of mixed performance, with technology stocks facing challenges and value-oriented segments gaining traction, investors are keenly observing the shifts in economic indicators such as cooling U.S. labor data and fluctuating manufacturing activity. In this context, identifying undervalued stocks can be particularly appealing as they may offer potential opportunities for growth amidst the broader market volatility and sector rotations.

If you are wondering whether Telefonaktiebolaget LM Ericsson’s current share price fairly reflects its potential, you are not alone. Many investors are asking the same question before making their next move. The stock last closed at SEK 97.2, with returns of a 2.3% decline over 7 days, 11.7% over 30 days, 10.1% year to date, 18.1% over 1 year, 81.0% over 3 years and 5.8% over 5 years. This gives investors plenty to think about in terms of changing sentiment and risk. Recent news coverage...

What the Lovable partnership could mean for Sinch Sinch (OM:SINCH) has just announced a partnership with Lovable, integrating its communications tools into the Lovable Cloud to support AI-built applications and production workloads across email, messaging, and voice. The collaboration starts with Sinch's Mailgun platform for email and could broaden into wider omnichannel services as Lovable users move from early prototypes to live customer facing products. See our latest analysis for...

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has supported investor sentiment, with major indices like Germany's DAX and France's CAC 40 posting gains. In this environment of cautious optimism and stable interest rates from the European Central Bank, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential market opportunities.

There's been a notable change in appetite for Asker Healthcare Group AB ( STO:ASKER ) shares in the week since its...

Scandi Standard AB (publ) ( STO:SCST ) shareholders have had their patience rewarded with a 27% share price jump in the...

The Tele2 AB (publ) ( STO:TEL2 B ) share price has done very well over the last month, posting an excellent gain of...

Sandvik AB (publ)'s ( STO:SAND ) dividend will be increasing from last year's payment of the same period to SEK6.00 on...

While it may not be enough for some shareholders, we think it is good to see the Elekta AB (publ) ( STO:EKTA B ) share...

The board of Vitec Software Group AB (publ) ( STO:VIT B ) has announced that it will pay a dividend of SEK0.90 per...

JLT Mobile Computers AB (publ) ( STO:JLT ) shareholders that were waiting for something to happen have been dealt a...

Hansa Biopharma (OM:HNSA) has reported full year 2025 results with fourth quarter revenue of SEK 76.0 million and a basic EPS loss of SEK 1.62, alongside a trailing twelve month EPS loss of SEK 6.52 on revenue of SEK 222.3 million. The company has seen quarterly revenue move between SEK 30.8 million and SEK 76.0 million across 2025, while quarterly basic EPS stayed in loss-making territory, ranging from SEK 0.55 to SEK 2.53 per share. For investors, the latest print keeps the focus squarely...

Why Camurus’ new 2026 guidance matters for shareholders Camurus (OM:CAMX) has set fresh 2026 guidance, flagging expected revenues of SEK 2.6b to SEK 2.9b and an operating result of SEK 0.9b to SEK 1.2b, alongside several portfolio milestones. See our latest analysis for Camurus. Camurus’ new 2026 guidance follows a 9.5% year to date share price return and a 14.2% total shareholder return over the past year, which builds on a very large 3 year total shareholder return of about 19x. This...

Skanska (OM:SKA B) has been busy adding new work, with fresh contracts in US transport and education, and UK offices that feed directly into its order book and future earnings pipeline. See our latest analysis for Skanska. At a latest share price of SEK266.6, Skanska has seen a 1-day share price return of 0.91% and a 7-day share price return decline of 3.93%, while a 90-day share price return of 7.72% and a 1-year total shareholder return of 8.10% suggest momentum that lines up with a steady...

Paradox Interactive (OM:PDX) just reported full year 2025 results that paired weaker profitability with a higher proposed dividend, a combination that is drawing fresh attention to the stock’s recent performance. See our latest analysis for Paradox Interactive. The annual results appear to have reset expectations, with the 1 month share price return of 19.47% and 3 month share price return of 27.00% weighing on sentiment. At the same time, the 1 year total shareholder return of 41.43% shows...

As the European market continues to show resilience amidst global volatility, with the pan-European STOXX Europe 600 Index reaching new highs and major indexes like Germany's DAX and France's CAC 40 posting gains, investors are increasingly optimistic about the eurozone economy. In this environment of cautious optimism, dividend stocks can offer a compelling opportunity for income-focused investors seeking stability and potential returns; these stocks typically provide regular payouts that...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

To the annoyance of some shareholders, Surgical Science Sweden AB (publ) ( STO:SUS ) shares are down a considerable 25...